EX-10.1





 Exhibit 10.1 

November 12, 2020 
 Organogenesis Holdings Inc. 

85 Dan Road 
 Canton, Massachusetts 02021 

Attn: Gary S. Gillheeney, Sr., President and Chief Executive Officer 
  

	 	Re:	 Fee Letter Agreement 



Ladies and Gentlemen: 
 This fee letter agreement
(the “Agreement”) confirms the agreement by and among Organogenesis Holdings Inc. (the “Company”), Avista Capital Partners IV, L.P. (“Avista IV”), Avista Capital Partners
(Offshore) IV, L.P. (“Avista IV Offshore” and together with Avista IV, the “Avista Funds”) and Avista Capital Holdings, L.P., an affiliate of the Avista Funds (the “Management
Company”), pursuant to which the Company hereby agrees to pay the Management Company a fee in consideration for certain services rendered in connection with Investments (as defined below) in the Company that may be made by the Avista
Funds. In connection with the Proposed Offering (as defined below), the Company’s underwriters have agreed that they shall not be entitled to a discount or fee for the portion of the aggregate gross proceeds of the Investments sold to the
Avista Funds. In consideration of the valuable services provided by the Management Company in connection with the Proposed Offering, if the Avista Funds participate in the Proposed Offering, the Company shall pay the Management Company a fee in an
amount equal to the portion of the aggregate gross proceeds of the Investments sold to the Avista Funds, if any, multiplied by a rate equal to the rate of the underwriters’ discount or spread in the Proposed Offering without giving effect to
any Investments sold to the Avista Funds. It being understood that no fee shall be payable hereunder if the Avista Funds do not participate in the Proposed Offering or if the Proposed Offering does not close on or before December 31, 2020. As
used herein, “Investments” are defined as the purchase of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), for cash pursuant to a proposed offering of
Common Stock to be made by the Company pursuant to a registration statement on Form S-1 (No. 333-249531) (the “Proposed Offering”). Any fee
payable to the Management Company by the Company hereunder, if any, shall be due and payable within five business days of the closing of the Proposed Offering. 

The Company represents and warrants to the Avista Funds and the Management Company that it has the requisite corporate power and authority and
power to enter into this Agreement and to consummate the transactions contemplated hereby and that such transactions shall not contravene any contractual, regulatory, statutory or other obligation or restriction applicable to the Company. 

Each of the Avista Funds and the Management Company, as to itself only, represents and warrants to the Company that it has the requisite power
and authority to enter into this Agreement and consummate the transactions contemplated hereby and that such transactions shall not contravene any contractual, regulatory, statutory or other obligation or restriction applicable to it. 

This agreement, and any action or proceeding arising out of or relating to this Agreement, shall be exclusively governed by the laws of the
State of Delaware. 
 In the event that any part of this Agreement is declared by any court or other judicial or administrative body to be
null, void or unenforceable, said provision shall survive to the extent it is not so declared, and all of the other provisions of this agreement shall remain in full force and effect. In such an event, the Avista Funds and the Company shall endeavor
in good faith negotiations to modify this agreement so as to affect the original intent of the parties as closely as possible. 












 This Agreement may be executed in two or more counterparts, each of which shall constitute
an original, but all of which, when taken together, shall constitute but one instrument, and shall become effective when one or more counterparts have been signed by each party hereto and delivered to the other parties. 

Please sign to acknowledge agreement with the above terms and return to the undersigned. 

 

			
	Avista Funds:
	
	Avista Capital Partners IV, L.P.
		
	By:	 	 /s/ Robert Girardi

	Name:	 	Robert Girardi
	Title:	 	Partner
	
	Avista Capital Partners (Offshore) IV, L.P.
		
	By:	 	 /s/ Robert Girardi

	Name:	 	Robert Girardi
	Title:	 	Partner
	
	Avista Capital Holdings, L.P.
		
	By:	 	 /s/ Benjamin Silbert

	Name:	 	Benjamin Silbert
	Title:	 	General Counsel


 Acknowledged and agreed to: 

Company: 
 Organogenesis Holdings Inc. 

 

			
	By:	 	 /s/ Henry Hagopian

	Name:	 	Henry Hagopian
	Title:	 	Interim Chief Financial Officer

 Signature Page to Fee Letter Agreement 

  
 2